Analyst
Jefferies
Equibles does not estimate personal net worth.
Noah is recorded as Analyst at Jefferies. Noah has spoken on 9 earnings calls across 4 companies, most recently for Natera, Inc. on August 6, 2026. Those appearances were for Quest Diagnostics Inc (DGX), Natera, Inc. (NTRA), Guardant Health, Inc. (GH) and BillionToOne, Inc. (BLLN). The companies whose calls Noah spoke on are classified in the Healthcare sector.
“I think the high single-digit growth is a little bit better than we were expecting. I'm curious, what are you seeing from an underlying market growth standpoint?”
“I wanted to ask about Garden360 tissue, clearly outgrowing the broader market in this application. I'm curious if you think these share gains are tied to maybe some of these concurrent testing trends with liquid that you've been talking about or an actual shift in provider preference.”
“I wanted to ask about PAMA as we get closer to the next phase of implementation here. How are you thinking about the potential reimbursement outcomes, and what actions can you take to offset potential future reimbursement risk?”
“I believe the partnership with GARDEN for SHIELD went live about a month ago, if you could speak to early adoption there. And just on Haystack, what should we be expecting in terms of the phasing of EPS contribution throughout the year and kind of getting to break even?”
“I wanted to start by asking about the health systems opportunity, particularly if you could provide any context on how you're sizing it and then what the timeline looks like for this to possibly show up in”
Jefferies
Analyst
Transcript header (unverified)
Diagnostics & Research · Healthcare
NTRA
Diagnostics & Research · Healthcare
BLLN
Diagnostics & Research · Healthcare
